Study of BL-M09D1 for advanced bladder cancer and other solid tumors
Part of Cancer clinical trials.
This trial tests an investigational drug called BL-M09D1 for people with advanced bladder cancer (urothelial carcinoma) or other solid tumors that have spread. The goal is to see if the drug can shrink tumors and help people live longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have advanced bladder cancer or another solid tumor that has spread.
- You are expected to live at least 3 more months.
- You have a tumor that can be measured on a scan.
- You are able to provide a tumor sample (from a past biopsy or a new one).
- You have not had certain other cancer treatments within the past month.
- You do not have serious heart, lung, or other health problems that would make the trial unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called BL-M09D1 for people with certain gynecologic cancers or other solid tumors that have not responded to standard treatment. The goal is to see if the drug can shrink tumors or slow their growth, and to check its safety.
This study tests an experimental drug called BL-M08D1 for people with recurrent or metastatic gynecological cancers and other solid tumors. The drug is designed to target and kill cancer cells, and the study aims to see if it is safe and effective.
This study tests a new drug called BL-M08D for people with advanced solid tumors, especially those in the digestive tract (like stomach, colon, or pancreas). The goal is to see if it is safe and effective, and it might help shrink tumors or slow their growth.
This trial tests a new drug, BL-M24D1, in people with advanced or metastatic digestive tract cancers or other solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This trial tests a new drug, BL-M09D1, for people with advanced or metastatic gastrointestinal or other solid tumors that have stopped responding to standard treatments. The goal is to see if the drug can shrink tumors and how safe it is.
This trial tests a new drug called BL-B16D1 for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if this drug is safe and how well it works.
Hear when a new Urothelial Carcinoma (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.